Sign in →

TEST ID RESSPAN RESPIRATORY VIRAL PANEL, PCR

Important Note

Detection and identification of multiple repiratory bacterial and viral nucleic acids directly from nasopharyngeal (NP) specimens obtained from individuals with signs/symptoms of respiratory tract infections.

**Recent administration of nasal influenza vaccine may cause false positive results for Influenza A and/or Influenza B**

Reportable targets include the following:

Adenovirus,  Coronavirus (229E, HKU1, NL63, OC43, SARS-CoV2),  Influenza A,  Influenza B,  Human Metapneumovirus,  Parainfluenza Virus (1,2, 3, & 4),  Respiratory Syncytial virus (RSV),  Rhinovirus/Enterovirus,  Bordetella pertussis,  Bordetella parapertussis,  Chlamydia pneumoniae,  and Mycoplasma pneumoniae.

Infectious

Performing Laboratory

NRLS-Microbiology

Specimen Type

Nasopharyngeal swabs (NP)

Specimen Required

Nasopharyngeal swab (NP) submitted in Viral or Universal transport media

Nasopharyngeal swabs (NP) submitted in dry, sterile container

Specimen Minimum Volume

One swab

Specimen Stability Information

Specimen Type Temperature Time
NP swab in transport media (Preferred) Ambient 4 hours
NP swab in transport media (Preferred) Refrigerated 3 days
NP swab in sterile dry container Refrigerated 24 hours

 

Reference Values

An interpretive report will be provided

Methodology

FDA approved multiplex RT-PCR with melt analysis 

Panel Profile

Reporting Name

Available
Separately

Test Code

Respiratory Syncytial virus

Yes

RSVPCR

Bordetella pertussis

Yes

PERTPCR

Influenza A & B

Yes

FLUPCR
SARS-CoV2 (COVID-19) Yes COVIDPCR

Adenovirus

No

 

Coronavirus (229E, HKU1, NL63, OC43)

No

 

Parainfluenza Virus (1, 2, 3, & 4)

No

 

Rhinovirus/Enterovirus

No

 

Bordetella parapertussis

No

 

Chlamydia pneumoniae

No

 

Mycoplasma pneumoniae

No